AMT

Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 10, 2021
UC, Autoimmunity, GI, CRP, Inflammation, IE, Therapy, R, G&A, Patient, Histology, Rheumatoid arthritis, Biology, Calprotectin, U.S. Securities and Exchange Commission, GMP, Technology, Security (finance), Securities Exchange Act of 1934, Ulcerative colitis, Terminology, Securities Act of 1933, Nasdaq, AMTI, AMT, SEC, Investment, Disease, GLOBE, CA, Microbiome, Growth, Magazine, Inflammatory Bowel Diseases, Epithelium, Pharmaceutical industry, Cryptocurrency, Medical device, Fine chemical

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.

Key Points: 
  • Total R&D expenses for the second quarter of 2021 were $16.5 million, compared to $12.8 million for the same period in 2020.
  • Total G&A expenses for the second quarter of 2021 were $7.1 million, compared to $2.5 million for the same period in 2020.
  • Net loss for the second quarter of 2021 was $23.6 million, compared to $15.4 million for the same period in 2020.
  • Active transport is an efficient mechanism that uses the cells own machinery to transport materials across the IE barrier.

Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference

Retrieved on: 
Thursday, August 5, 2021
Biology, GLOBE, Nasdaq, CA, AMTI, Ie, GMP, Autoimmunity, Conference, SAN, AMT, Disease, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord Genuitys 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:30 p.m.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during Canaccord Genuitys 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:30 p.m.
  • A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events .
  • About Applied Molecular Transport Inc.
  • Active transport is an efficient mechanism that uses the cells own machinery to transport materials across the IE barrier.

American Tower Corporation to Present at the Credit Suisse 23rd Annual Communications Conference

Retrieved on: 
Thursday, June 10, 2021
Technology, Other Construction & Property, Telecommunications, Commercial Building & Real Estate, Construction & Property, REIT, Real estate investment trust, AMT, American Tower

American Tower Corporation (NYSE: AMT) today announced that Rod Smith, its Executive Vice President, Chief Financial Officer and Treasurer, is scheduled to present at the Credit Suisse 23rd Annual Communications Conference, on Monday, June 14, 2021 at 10:25 a.m.

Key Points: 
  • American Tower Corporation (NYSE: AMT) today announced that Rod Smith, its Executive Vice President, Chief Financial Officer and Treasurer, is scheduled to present at the Credit Suisse 23rd Annual Communications Conference, on Monday, June 14, 2021 at 10:25 a.m.
  • A live audio webcast link for the virtual event will be available on the Company's website.
  • American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 214,000 communications sites.
  • For more information about American Tower, please visit www.americantower.com .

American Tower Corporation to Present at Nareit's REITweek: 2021 Virtual Investor Conference

Retrieved on: 
Friday, June 4, 2021
Telecommunications, Commercial Building & Real Estate, Construction & Property, Technology, REIT, Other Construction & Property, Mobile, Wireless, Other Technology, Real estate investment trust, National Association of Real Estate Investment Trusts, American Tower, Australian real estate investment trust, AMT, Real estate industry, Finance, Real estate

American Tower Corporation (NYSE: AMT) today announced that Tom Bartlett, its President and Chief Executive Officer, is scheduled to present at Nareits REITweek: 2021 Virtual Investor Conference, on Wednesday, June 9, 2021 at 10:15 a.m.

Key Points: 
  • American Tower Corporation (NYSE: AMT) today announced that Tom Bartlett, its President and Chief Executive Officer, is scheduled to present at Nareits REITweek: 2021 Virtual Investor Conference, on Wednesday, June 9, 2021 at 10:15 a.m.
  • A live audio webcast link for the virtual event will be available on the Company's website.
  • American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 214,000 communications sites.
  • For more information about American Tower, please visit www.americantower.com .

American Tower Corporation to Present at the J.P. Morgan 49th Annual Global Technology, Media and Communications Conference

Retrieved on: 
Wednesday, May 19, 2021
Technology, Mobile, Wireless, Telecommunications, Commercial Building & Real Estate, Construction & Property, REIT, Real estate investment trust, AMT, American Tower

b"American Tower Corporation (NYSE:AMT) today announced that Rod Smith, its Executive Vice President, Chief Financial Officer and Treasurer, is scheduled to present at the J.P. Morgan 49th Annual Global Technology, Media and Communications Conference, on Monday, May 24, 2021 at 10:15 a.m.

Key Points: 
  • b"American Tower Corporation (NYSE:AMT) today announced that Rod Smith, its Executive Vice President, Chief Financial Officer and Treasurer, is scheduled to present at the J.P. Morgan 49th Annual Global Technology, Media and Communications Conference, on Monday, May 24, 2021 at 10:15 a.m.
  • ET.
  • A live audio webcast link for the virtual event will be available on the Company's website.\nAmerican Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 187,000 communications sites.
  • For more information about American Tower, please visit www.americantower.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519005805/en/\n"

American Tower Corporation to Present at the Moffett Nathanson 8th Annual Media & Communications Summit

Retrieved on: 
Friday, May 7, 2021
Other Construction & Property, Construction & Property, REIT, Real estate investment trust, Nathanson, AMT

b"American Tower Corporation (NYSE: AMT) today announced that Igor Khislavsky, its Vice President, Investor Relations, is scheduled to present at the Moffett Nathanson 8th Annual Media & Communications Summit on Wednesday, May 12, 2021 at 2:00 p.m.

Key Points: 
  • b"American Tower Corporation (NYSE: AMT) today announced that Igor Khislavsky, its Vice President, Investor Relations, is scheduled to present at the Moffett Nathanson 8th Annual Media & Communications Summit on Wednesday, May 12, 2021 at 2:00 p.m.
  • ET.
  • The live audio webcast link for the virtual event will be available on the Company's website.\nAmerican Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 187,000 communications sites.
  • For more information about American Tower, please visit www.americantower.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210507005487/en/\n"

Applied Molecular Transport Appoints Earl Douglas as General Counsel

Retrieved on: 
Monday, March 22, 2021
AMT

Company expanded clinical pipeline with second program, oral AMT-126, and announced first subject dosed in Phase 1a trial in February 2021

Key Points: 
  • Company expanded clinical pipeline with second program, oral AMT-126, and announced first subject dosed in Phase 1a trial in February 2021
    SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that it has appointed Earl Douglas as General Counsel.
  • Mr. Douglas most recently served as general counsel at Kiverdi.
  • I am thrilled to be joining AMT at such an important point in the Companys growth, said Earl Douglas, general counsel of AMT.
  • Active transport is an efficient mechanism that uses the cells own machinery to transport materials across the IE barrier.

Applied Molecular Transport Expands Clinical Pipeline and Announces First Subject Dosed in Phase 1a Trial of Oral AMT-126

Retrieved on: 
Monday, March 1, 2021
Life sciences, Biotechnology, Health sciences, Pharmaceutical industry, Biopharmaceutical, Pharmacy, AMT

The randomized, placebo controlled, single ascending dose Phase 1a trial is evaluating the safety, tolerability, pharmacodynamics and pharmacokinetics of AMT-126, a novel, gastrointestinal (GI)-selective oral fusion of human interleukin-22 (hIL-22), in up to 50 healthy volunteers.

Key Points: 
  • The randomized, placebo controlled, single ascending dose Phase 1a trial is evaluating the safety, tolerability, pharmacodynamics and pharmacokinetics of AMT-126, a novel, gastrointestinal (GI)-selective oral fusion of human interleukin-22 (hIL-22), in up to 50 healthy volunteers.
  • Advancing AMT-126 into the clinic further validates AMTs broad oral biologics technology platform and we look forward to generating additional pipeline products to address diseases with significant unmet needs.
  • Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.
  • Active transport is an efficient mechanism that uses the cells own machinery to transport materials across the IE barrier.

American Medical Technologies Notifies Consumers of Data Security Incident

Retrieved on: 
Friday, June 19, 2020
Cryptography, Information governance, Computer network security, Cybercrime, Cyberwarfare, AMT, Computer security, Information Age, Intel Active Management Technology

IRVINE, Calif., June 18, 2020 /PRNewswire/ --American Medical Technologies ("AMT") has become aware of a data security incident that may have involved the personal information of certain AMT customers.

Key Points: 
  • IRVINE, Calif., June 18, 2020 /PRNewswire/ --American Medical Technologies ("AMT") has become aware of a data security incident that may have involved the personal information of certain AMT customers.
  • AMT has sent notification to those potentially-impacted individuals who have been identified in order to notify them about this incident and to offer complimentary credit monitoring services to them.
  • After an extensive and comprehensive investigation and data mining process, on May 14, 2020, AMT determined that personal information may have been available to the attacker during the incident.
  • AMT also implemented additional safeguards to improve data security on our web server infrastructure.

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Retrieved on: 
Tuesday, June 9, 2020
Financial markets, Finance, Stock market, Financial economics, Corporate finance, Stock, AMTS, AMT, NASDAQ

The aggregate total gross proceeds to AMT from the offering were $177.1 million, before deducting underwriting discounts and commissions and other offering expenses.

Key Points: 
  • The aggregate total gross proceeds to AMT from the offering were $177.1 million, before deducting underwriting discounts and commissions and other offering expenses.
  • All of the shares in the offering were offered by AMT.
  • AMTs common stock began trading on the Nasdaq Global Select Market on June 5, 2020, under the ticker symbol AMTI.
  • Active transport is an efficient mechanism that uses the cells own machinery to transport materials across the IE barrier.